Search results
Found 123 matches for
New research led by Department of Physiology, Anatomy & Genetics researcher Dr Kerstin Timm shows that a recently developed imaging technique can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.
Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine
General Innovation Research
16 April 2024
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.
Oxford spinout Brainomix is revolutionising stroke care through AI
General Innovation Research
16 February 2024
This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by a University of Oxford spinout company are ensuring that more stroke patients will receive better care and outcomes.
Innovative Imaging solution offers potential breakthrough in endometriosis detection
General Innovation Research
19 January 2024
The DETECT study, led by Nuffield Department of Women's and Reproductive Health Professors Christian Becker and Krina Zondervan explores the potential of visualizing endometriosis, including hard-to-detect superficial peritoneal disease, using Serac's innovative imaging agent.
Next step in plans for Warneford Park
General Innovation
8 January 2024
Plans for Warneford Park have taken a step forward as partners in the project signed a Conditional Option Agreement (COA) and Memorandum of Understanding (MOU), agreeing how they will work together going forward.
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa
General Innovation Research
6 November 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
Celebrating 5 Years of the BioEscalator
General Innovation
1 November 2023
The BioEscalator recently marked its 5th anniversary with a celebration that showcased the impressive journeys of some of its current and graduated biotech companies.
New AI tool could help predict viral outbreaks
General Innovation Research
19 October 2023
As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers at the University of Oxford and Harvard Medical School could help predict new viral variants before they emerge. The findings have been published in the journal Nature.
Tackling mental illness by supporting industry to develop new drugs
General Innovation Research
11 October 2023
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
Wearable sensors provide early detection of progression in Parkinson’s Disease
General Innovation Research
11 October 2023
A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson’s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
Oxford researchers develop 3D printing method that shows promise for repairing brain injuries
General Innovation Research
5 October 2023
A breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer brain injuries. The researchers demonstrated for the first time that neural cells can be 3D printed to mimic the architecture of the cerebral cortex. These results have been published today in the journal Nature Communications.
Oxford-Harrington Rare Disease Centre launches pioneering Therapeutics Accelerator to advance inovative treatments for rare diseases
General Innovation Research
3 October 2023
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.
Three new Oxford-BMS Translational Fellowships announced
General Innovation Research
11 September 2023
Ageing beyond earth: Oxford opens the UK’s first Space Innovation Lab
General Innovation Research
6 July 2023
The UK’s first Space Innovation Lab, dedicated to understanding the effect of space microgravity on the ageing process, opens at the Botnar Institute today.
Record number of unicorn founders from the University of Oxford
General Innovation
27 June 2023
The University of Oxford has produced the highest number of tech unicorn founders across Europe, according to a new report.
Beacon Therapeutics spun out by Syncona and Oxford raises £96 million for retinal gene therapy
General Innovation Research
12 June 2023
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
Oxford retains top spot for spinouts
General Innovation
23 May 2023
The University of Oxford has held its position as the leading academic institution in the UK for generating spinout companies, according to a new report by data analyst firm Beauhurst.
Brain and mental health innovation at Oxford
General Innovation Research
22 May 2023
Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.
How mental health treatments are being extended with virtual reality
General Innovation Research
22 May 2023
Nearly one billion people worldwide suffer from some form of mental disorder, according to UN data, but relatively few can access the treatment they need. Innovative AI based therapy, developed by researchers at Oxford, is now enabling a greater number of people to get help.
Universities boost investor confidence with new spinout framework to spur economic growth
General Innovation
26 April 2023
The University of Oxford has partnered with other institutions and investors to agree terms which will greatly increase the UK’s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
£12 million investment for Future Vaccines Manufacturing Hub
General Innovation Research
12 April 2023
A new Future Vaccines Manufacturing Hub aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.